Gastrointestinal Integrity After Naproxen + Rebamipide Versus Naproxen + Placebo

NCT02632812 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Lesions

Interventions

DRUG: Rebamipide effervescent granules
DRUG: Placebo effervescent granules
DRUG: Naproxen tablet

Sponsor

Biolab Sanus Farmaceutica